Hollsteen
← Marvell

Equity incl. NCI

Balance – as of period end · $B

QuartersFiscal years

$BEquity incl. NCI · Q1 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q1 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q1 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q1 FY2019: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 FY2019: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 FY2019: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 FY2019: $7.3B · 10-K 0001835632-22-000016 filed Mar 10, 2022Equity incl. NCI · Q1 FY2020: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 FY2020: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 FY2020: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 FY2020: $8.7B · 10-K 0001835632-23-000013 filed Mar 9, 2023Equity incl. NCI · Q1 FY2021: $8.5B · 10-Q 0001835632-21-000010 filed Jun 9, 2021Equity incl. NCI · Q2 FY2021: $8.4B · 10-Q 0001835632-21-000022 filed Aug 27, 2021Equity incl. NCI · Q3 FY2021: $8.4B · 10-Q 0001835632-21-000032 filed Dec 3, 2021Equity incl. NCI · Q4 FY2021: $8.4B · 10-K 0001835632-23-000013 filed Mar 9, 2023Equity incl. NCI · Q1 FY2022: $14.9B · 10-Q 0001835632-22-000028 filed May 27, 2022Equity incl. NCI · Q2 FY2022: $14.7B · 10-Q 0001835632-22-000041 filed Aug 26, 2022Equity incl. NCI · Q3 FY2022: $15.7B · 10-Q 0001835632-22-000053 filed Dec 2, 2022Equity incl. NCI · Q4 FY2022: $15.7B · 10-K 0001835632-23-000013 filed Mar 9, 2023Equity incl. NCI · Q1 FY2023: $15.5B · 10-Q 0001835632-22-000028 filed May 27, 2022Equity incl. NCI · Q2 FY2023: $15.5B · 10-Q 0001835632-22-000041 filed Aug 26, 2022Equity incl. NCI · Q3 FY2023: $15.6B · 10-Q 0001835632-22-000053 filed Dec 2, 2022Equity incl. NCI · Q4 FY2023: $15.6B · 10-K 0001835632-23-000013 filed Mar 9, 2023Equity incl. NCI · Q1 FY2024: $15.5B · 10-Q 0001835632-23-000029 filed May 26, 2023Equity incl. NCI · Q2 FY2024: $15.4B · 10-Q 0001835632-23-000038 filed Aug 25, 2023Equity incl. NCI · Q3 FY2024: $15.2B · 10-Q 0001835632-23-000046 filed Dec 1, 2023Equity incl. NCI · Q4 FY2024: $14.8B · 10-K 0001835632-24-000009 filed Mar 13, 2024Equity incl. NCI · Q1 FY2025: $14.5B · 10-Q 0001835632-24-000063 filed May 31, 2024Equity incl. NCI · Q2 FY2025: $14.2B · 10-Q 0001835632-24-000142 filed Aug 30, 2024Equity incl. NCI · Q3 FY2025: $13.4B · 10-Q 0001835632-24-000200 filed Dec 4, 2024Equity incl. NCI · Q4 FY2025: $13.4B · 10-K 0001835632-25-000057 filed Mar 12, 2025Equity incl. NCI · Q1 FY2026: $13.3B · 10-Q 0001835632-25-000117 filed May 30, 2025Equity incl. NCI · Q2 FY2026: $13.4B · 10-Q 0001835632-25-000189 filed Aug 29, 2025Equity incl. NCI · Q3 FY2026: $14.1B · 10-Q 0001835632-25-000197 filed Dec 3, 2025Equity incl. NCI · Q4 FY2026: $14.3B · 10-K 0001835632-26-000011 filed Mar 11, 2026Equity incl. NCI · Q1 FY2027: $18.2B · 10-Q 0001835632-26-000019 filed May 28, 2026Equity incl. NCI · Q2 FY2027: $18.5B · 10-Q 0001835632-26-000025 filed Aug 28, 2026missing18.57.3Q1 FY2016Q2 FY2027Q3 FY2019
Q3 FY2019
None

No SEC data for MRVL equity_total in FY2019 Q3: outside the stored range FY2019–FY2027 Q2 (latest fiscal year FY2026, latest period FY2027 Q2). Use a period in that range, period='latest', or get_series(company='MRVL', metric='equity_total') for the full series.

All values (28)
PeriodValue ($B)Status
Q2 FY202718.5reported
Q1 FY202718.2reported
Q4 FY202614.3reported
Q3 FY202614.1reported
Q2 FY202613.4reported
Q1 FY202613.3reported
Q4 FY202513.4reported
Q3 FY202513.4reported
Q2 FY202514.2reported
Q1 FY202514.5reported
Q4 FY202414.8reported
Q3 FY202415.2reported
Q2 FY202415.4reported
Q1 FY202415.5reported
Q4 FY202315.6reported
Q3 FY202315.6reported
Q2 FY202315.5reported
Q1 FY202315.5reported
Q4 FY202215.7reported
Q3 FY202215.7reported
Q2 FY202214.7reported
Q1 FY202214.9reported
Q4 FY20218.4reported
Q3 FY20218.4reported
Q2 FY20218.4reported
Q1 FY20218.5reported
Q4 FY20208.7reported
Q4 FY2019Noneerror

18 periods without value hidden · Show gaps with reason · CSV with all sources · Technical ID: equity_total

More metrics for Marvell